FindTrial
Sign In

Effectiveness of using 200IU hCG to replace FSH during the late follicular phase in women undergoing COH for assisted reproduction

Effectiveness of using 200IU hCG to replace FSH during the late follicular phase in women undergoing COH for assisted reproduction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063958
Enrollment
Unknown
Registered
2022-09-21
Start date
2022-10-10
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Regular platoon promotion group:urotropin
hCG replacement group:HMG+200IUhCG

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: Patients aged 20-38 years who underwent cryopreservation of whole embryo and cryopreservation of freeze-thawed embryo transfer (FET) at a later date.

Exclusion criteria

Exclusion criteria: 1. Previous IVF failure history of more than 2 times; 2. Previous history of empty eggs; 3. Endometriosis grade III or above; 4. Complicated with serious systemic diseases; 5. Patients with early-onset ovarian insufficiency and premature ovarian failure; 6. Patients with polycystic ovary syndrome; 7. Pre-implantation genetic screening cycle.

Design outcomes

Primary

MeasureTime frame
the number of viable embryo;—

Secondary

MeasureTime frame
the number of oocytes retrieved;the number of mature oocytes;the clinical pregnancy rate;incidence of ovarian hyperstimulation;the implantation rate;the early miscarriage rate;—

Countries

China

Contacts

Public ContactFu Yonglun
fuyonglun2022@163.com+86 13917547302

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026